American National Bank & Trust’s Novo Nordisk NVO Stock Holding History

American National Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.6K	Hold	513	–	–	﹤0.01%	421
2026 Q1	$18.9K	Sell	513 -30	-6%	-$1.42K	﹤0.01%	443
2025 Q4	$27.6K	Buy	+543	New	+$27.8K	﹤0.01%	421
2025 Q3	–	Sell	-7,005	Closed	-$483K	–	678
2025 Q2	$483K	Sell	7,005 -13	-0.2%	-$884	0.05%	172
2025 Q1	$487K	Buy	7,018 +13	+0.2%	+$1.07K	0.05%	154
2024 Q4	$603K	Hold	7,005	–	–	0.07%	126
2024 Q3	$834K	Hold	7,005	–	–	0.1%	108
2024 Q2	$1,000K	Hold	7,005	–	–	0.12%	89
2024 Q1	$899K	Buy	7,005 +2,335	+50%	+$278K	0.12%	104
2023 Q4	$483K	Hold	4,670	–	–	0.08%	124
2023 Q3	$425K	Hold	4,670	–	–	0.07%	124
2023 Q2	$378K	Hold	4,670	–	–	0.06%	127
2023 Q1	$372K	Buy	+4,670	New	+$331K	0.07%	123
2016 Q2	–	Sell	-900	Closed	-$24K	–	259
2016 Q1	$24K	Hold	900	–	–	0.01%	138
2015 Q4	$26K	Hold	900	–	–	0.01%	145
2015 Q3	$24K	Buy	+900	New	+$25.5K	0.01%	156

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

GIM

Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

American National Bank & Trust's NVO Position: Q2 2026 in Review

American National Bank & Trust held its Novo Nordisk (NVO) position steady in Q2 2026 at 513 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #421.

American National Bank & Trust first reported a position in NVO in Q3 2015 and has held it in 16 quarters since. The position peaked at $1,000K in Q2 2024. 479 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

American National Bank & Trust held 513 shares of Novo Nordisk worth $24.6K as of Q2 2026.
American National Bank & Trust left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of American National Bank & Trust's portfolio in Q2 2026, its #421 holding.
American National Bank & Trust first reported a position in Novo Nordisk in Q3 2015 and has held it in 16 quarters since.
American National Bank & Trust's Novo Nordisk position peaked at $1,000K in Q2 2024.
479 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.